Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;234(9):14680-14688.
doi: 10.1002/jcp.28221. Epub 2019 Jan 29.

Hypolipidemic effects of Rosmarinus officinalis L

Tahereh Farkhondeh  1 , Saeed Samarghandian  2 , Ali Mohammad Pourbagher-Shahri  3
Affiliations
Review

Hypolipidemic effects of Rosmarinus officinalis L

Tahereh Farkhondeh et al. J Cell Physiol. 2019 Sep.

Abstract

Dyslipidemia is one of the major risk factors for cardiovascular diseases (CVDs). Current strategies are not effective in the management of dyslipidemia. Thus, there is a necessity to find new preventative and therapeutic approaches. In recent years, herbal medicine has drawn great attention regarding the prevention and management of dyslipidemia. Rosmarinus officinalis, commonly known as rosemary, is an evergreen shrub containing several polyphenols. The plant grows in the Mediterranean and South American regions. Rosemary and its main components have antioxidant, anti-inflammatory, and lipid-lowering properties. The present review has focused on in vivo and in vitro studies on the hypolipidemic effects of rosemary and its main constituents as well as their functional mechanisms. Studies have described lipid-scavenging activities of rosemary through its flavonoid contents. Modulating inflammation and oxidative stress have been described as possible mechanisms by which rosemary ameliorates dyslipidemia. However, the exact mechanisms are not fully understood yet. Conducting experimental and clinical trial studies are recommended to confirm the safety and efficacy of rosemary in the prevention and management of dyslipidemia and other cardio-metabolic diseases.

Keywords: carnosic acid; carnosol; dyslipidemia; rosemary; rosmarinic acid.

PubMed Disclaimer

References

REFERENCES
    1. Amel, B. (2013). Traditional treatment of high blood pressure and diabetes in Souk Ahras District. Journal of Pharmacognosy and Phytotherapy, 5(1), 12-20.
    1. Abdulrahim, A. J. (2014). Effect of rosemary (Rosmarinus officinalis) on lipid profiles and blood glucose in human diabetic patients (type-2). African Journal of Biochemistry Research, 8, 147-150.
    1. Afonso, M. S., de O Silva, A. M., Carvalho, E. B., Rivelli, D. P., Barros, S. B., Rogero, M. M., … Mancini-Filho, J. (2013). Phenolic compounds from rosemary (Rosmarinus officinalis L.) attenuate oxidative stress and reduce blood cholesterol concentrations in diet-induced hypercholesterolemic rats. Nutrition and Metabolism, 10, 19.
    1. Al Disi, S. S., Anwar, M. A., & Eid, A. H. (2016). Anti-hypertensive herbs and their mechanisms of action: Part I. Frontiers in Pharmacology, 6, 323.
    1. Alinejad, S., Aaseth, J., Abdollahi, M., Hassanian-Moghaddam, H., & Mehrpour, O. (2018). Clinical aspects of opium adulterated with lead in Iran: A review. Basic & Clinical Pharmacology & Toxicology, 122(1), 56-64. https://doi.org/10.1111/bcpt.12855

LinkOut - more resources